Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$63.71 - $70.74 $26,057 - $28,932
-409 Reduced 5.87%
6,559 $419,000
Q1 2023

May 09, 2023

BUY
$65.71 - $74.53 $394 - $447
6 Added 0.09%
6,968 $482,000
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $48,209 - $57,087
-704 Reduced 9.18%
6,962 $500,000
Q2 2022

Aug 10, 2022

BUY
$72.62 - $79.98 $356,854 - $393,021
4,914 Added 178.56%
7,666 $590,000
Q1 2022

Jun 28, 2022

SELL
$61.48 - $73.72 $106,852 - $128,125
-1,738 Reduced 38.71%
2,752 $201,000
Q1 2022

May 10, 2022

SELL
$61.48 - $73.72 $210,569 - $252,491
-3,425 Reduced 43.27%
4,490 $328,000
Q4 2021

Jun 28, 2022

BUY
$53.63 - $62.52 $37,916 - $44,201
707 Added 9.81%
7,915 $494,000
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $60,172 - $70,147
-1,122 Reduced 13.47%
7,208 $449,000
Q3 2021

Jun 28, 2022

SELL
$59.17 - $69.31 $102,837 - $120,460
-1,738 Reduced 17.26%
8,330 $493,000
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $83,548 - $97,865
1,412 Added 16.31%
10,068 $596,000
Q2 2021

Jun 28, 2022

SELL
$61.91 - $67.42 $154,279 - $168,010
-2,492 Reduced 22.35%
8,656 $578,000
Q2 2021

Aug 09, 2021

BUY
$61.91 - $67.42 $467,420 - $509,021
7,550 Added 209.84%
11,148 $745,000
Q1 2021

Jun 28, 2022

SELL
$59.34 - $66.74 $147,875 - $166,316
-2,492 Reduced 40.92%
3,598 $227,000
Q1 2021

May 13, 2021

BUY
$59.34 - $66.74 $9,850 - $11,078
166 Added 2.8%
6,090 $384,000
Q4 2020

Feb 11, 2021

BUY
$57.74 - $65.43 $156,071 - $176,857
2,703 Added 83.92%
5,924 $367,000
Q3 2020

Nov 02, 2020

BUY
$57.43 - $63.64 $4,824 - $5,345
84 Added 2.68%
3,221 $194,000
Q2 2020

Jul 29, 2020

BUY
$54.82 - $64.09 $171,970 - $201,050
3,137 New
3,137 $184,000
Q4 2017

Feb 12, 2018

SELL
$59.94 - $65.35 $106,633 - $116,257
-1,779 Closed
0 $0
Q3 2017

Nov 08, 2017

BUY
$55.23 - $63.74 $98,254 - $113,393
1,779
1,779 $113,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Stelac Advisory Services LLC Portfolio

Follow Stelac Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stelac Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stelac Advisory Services LLC with notifications on news.